1letý cíl společnosti Acelrx Pharmaceuticals Inc
Jaká je hodnota metriky 1letý cíl společnosti Acelrx Pharmaceuticals Inc?
Hodnota metriky 1letý cíl společnosti Acelrx Pharmaceuticals Inc je $5 +477.91%
Jaká je definice metriky 1letý cíl?
1-letý cíl (1-year target) je analytiky předpokládaná cena akcie za rok od dnešního dne.
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
1letý cíl společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Acelrx Pharmaceuticals Inc
Čemu se věnuje společnost Acelrx Pharmaceuticals Inc?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Firmy s metrikou 1letý cíl podobnou společnosti Acelrx Pharmaceuticals Inc
- Hodnota metriky 1letý cíl společnosti Goldlion je HKD$5 +443.96%
- Hodnota metriky 1letý cíl společnosti MPC Münchmeyer Petersen Capital AG je €5 +10.99%
- Hodnota metriky 1letý cíl společnosti Zhejiang Shibao je HKD$6 +187.16%
- Hodnota metriky 1letý cíl společnosti i-80 Gold je CAD$6 +380.85%
- Hodnota metriky 1letý cíl společnosti Cedar Woods Properties je AUD$5 -12.98%
- Hodnota metriky 1letý cíl společnosti Vista Gold je CAD$7 +656.34%
- Hodnota metriky 1letý cíl společnosti Acelrx Pharmaceuticals Inc je $5 +477.91%
- Hodnota metriky 1letý cíl společnosti Ramaco Resources Inc je $5 -48.34%
- Hodnota metriky 1letý cíl společnosti Nanfang Communication je HKD$6 +9,549.27%
- Hodnota metriky 1letý cíl společnosti Tianjin Capital Environmental Protection je HKD$6 +111.30%
- Hodnota metriky 1letý cíl společnosti Silverback Therapeutics je $5 -14.82%
- Hodnota metriky 1letý cíl společnosti ImmuPharma Plc je GBX500 +31,747.13%
- Hodnota metriky 1letý cíl společnosti Gulf Island Fabrication je $5 -5.66%